z-logo
Premium
Radiosynthesis of [ 11 C]docetaxel
Author(s) -
van Tilburg E. W.,
Franssen E. J. F.,
van der Hoeven J. J. M.,
van der Meij M.,
Elshove D.,
Lammertsma A. A.,
Windhorst A. D.
Publication year - 2004
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.861
Subject(s) - docetaxel , chemistry , radiosynthesis , moiety , yield (engineering) , radiochemistry , positron emission tomography , stereochemistry , nuclear medicine , cancer , medicine , materials science , metallurgy
Docetaxel (Taxotere®) is an accepted chemotherapeutic agent for the treatment of breast cancer and non‐small cell lung cancers. A potential means of predicting response is measuring tumor uptake of [ 11 C]docetaxel using Positron Emission Tomography (PET). The synthetic approach to introduce the 11 C isotope in the 2‐benzoyl moiety of docetaxel unfortunately was unsuccessful. The radiosynthesis of [ 11 C]docetaxel ( 6b , Scheme 1), with the 11 C isotope in the BOC moiety, was however, successful using a second synthetic approach. It started with the reaction of [ 11 C] tert ‐butanol with 1,2,2,2‐tetrachloroethyl chloroformate to give [ 11 C] tert ‐butyl‐l,2,2,2‐tetrachloroethyl carbonate in a good overall yield (62±9%). In the final step, the [ 11 C] tert ‐butoxycarbonylation of the free amine of docetaxel gave [ 11 C]docetaxel 6b in a satisfactory decay corrected yield of 10±1% (from [ 11 C]CO 2 ). Copyright © 2004 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom